AKT1 and neoplasm: Third, LINC00511 can accelerate tumor progression through regulating several tumor-associated signaling pathways such as RXRA/PLD1 [36], PTEN/AKT/FOXO1 [37], p38 [21], ERK1/2 [21] and JNK [21] pathways.